Zhejiang Wanfeng Chemical Co.,Ltd. (SHA:603172)
China · Delayed Price · Currency is CNY 21.87
0.00 (0.00%)
At close: May 6, 2026
Zhejiang Wanfeng Chemical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 552.15 | 531.35 | 500.87 | 534.82 | 555.57 |
Other Revenue | - | 3.79 | 2.69 | 10.36 | 8.1 |
| 552.15 | 535.13 | 503.56 | 545.18 | 563.66 | |
Revenue Growth (YoY) | 3.18% | 6.27% | -7.63% | -3.28% | 9.15% |
Cost of Revenue | 404.66 | 412.53 | 382 | 402.01 | 397.78 |
Gross Profit | 147.49 | 122.6 | 121.56 | 143.17 | 165.89 |
Selling, General & Admin | 70.24 | 62.25 | 60.17 | 51.07 | 51.58 |
Research & Development | 20.2 | 18.44 | 16.59 | 19.22 | 22.59 |
Other Operating Expenses | 1.42 | 2.92 | 1.49 | 2.93 | 2.9 |
Operating Expenses | 91.86 | 85.41 | 83.89 | 72.84 | 77.12 |
Operating Income | 55.63 | 37.19 | 37.67 | 70.33 | 88.77 |
Interest Expense | - | -4.15 | -3.25 | -2.01 | -2.16 |
Interest & Investment Income | 0.12 | 11.43 | 7.31 | 1.38 | 1.11 |
Currency Exchange Gain (Loss) | - | 1.59 | 0.93 | 5.03 | -2.76 |
Other Non Operating Income (Expenses) | 1.77 | -0.55 | -0.33 | -0.12 | 0.66 |
EBT Excluding Unusual Items | 57.52 | 45.51 | 42.33 | 74.61 | 85.62 |
Gain (Loss) on Sale of Investments | - | -0.02 | -0.05 | -0.11 | - |
Gain (Loss) on Sale of Assets | -0.01 | -0.04 | -0.08 | -0.63 | - |
Asset Writedown | -1.27 | - | - | - | -0.01 |
Other Unusual Items | - | 0.73 | 5.53 | 4.2 | 0.84 |
Pretax Income | 56.25 | 46.18 | 47.73 | 78.07 | 86.44 |
Income Tax Expense | 7.21 | 6.89 | 6.8 | 9.67 | 10.29 |
Earnings From Continuing Operations | 49.04 | 39.29 | 40.94 | 68.41 | 76.16 |
Minority Interest in Earnings | -0.78 | -0.96 | -0.48 | -0.79 | -1.11 |
Net Income | 48.26 | 38.33 | 40.45 | 67.62 | 75.05 |
Net Income to Common | 48.26 | 38.33 | 40.45 | 67.62 | 75.05 |
Net Income Growth | 25.91% | -5.25% | -40.18% | -9.90% | -14.10% |
Shares Outstanding (Basic) | 134 | 132 | 119 | 99 | 100 |
Shares Outstanding (Diluted) | 134 | 132 | 119 | 99 | 100 |
Shares Change (YoY) | 1.43% | 11.09% | 19.65% | -0.56% | - |
EPS (Basic) | 0.36 | 0.29 | 0.34 | 0.68 | 0.75 |
EPS (Diluted) | 0.36 | 0.29 | 0.34 | 0.68 | 0.75 |
EPS Growth | 24.14% | -14.71% | -50.00% | -9.33% | -13.79% |
Free Cash Flow | -46.21 | -7.56 | -44.32 | 45.16 | 31.15 |
Free Cash Flow Per Share | -0.34 | -0.06 | -0.37 | 0.45 | 0.31 |
Dividend Per Share | - | 0.090 | 0.100 | - | 0.200 |
Dividend Growth | - | -10.00% | - | - | -33.33% |
Gross Margin | 26.71% | 22.91% | 24.14% | 26.26% | 29.43% |
Operating Margin | 10.08% | 6.95% | 7.48% | 12.90% | 15.75% |
Profit Margin | 8.74% | 7.16% | 8.03% | 12.40% | 13.31% |
Free Cash Flow Margin | -8.37% | -1.41% | -8.80% | 8.28% | 5.53% |
EBITDA | 90.96 | 68.93 | 63.66 | 92.6 | 107.09 |
EBITDA Margin | 16.47% | 12.88% | 12.64% | 16.98% | 19.00% |
D&A For EBITDA | 35.33 | 31.74 | 25.99 | 22.26 | 18.32 |
EBIT | 55.63 | 37.19 | 37.67 | 70.33 | 88.77 |
EBIT Margin | 10.08% | 6.95% | 7.48% | 12.90% | 15.75% |
Effective Tax Rate | 12.82% | 14.92% | 14.24% | 12.38% | 11.90% |
Revenue as Reported | - | 535.13 | 503.56 | 545.18 | 563.66 |
Advertising Expenses | - | 0.72 | 0.61 | 0.4 | 0.08 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.